Semustine (MeccNU)

DRUG2 trials

Sponsors

He Huang

Conditions

Hematologic DiseaseHematologic Diseases

Phase 1

Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation

RecruitingNCT06809699

He HuangHematologic Diseases

Start: 2022-08-04End: 2027-10-31Target: 29Updated: 2025-02-05

Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

RecruitingNCT06809712

He HuangHematologic Disease

Start: 2022-08-04End: 2027-10-31Target: 29Updated: 2025-02-05